Europe Smart Pulse Oximeters Market Size, Share & Industry Trends Analysis Report By Type, By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Home Environment), By Country and Growth Forecast, 2022 - 2028
Description
Europe Smart Pulse Oximeters Market Size, Share & Industry Trends Analysis Report By Type, By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Home Environment), By Country and Growth Forecast, 2022 - 2028
The Europe Smart Pulse Oximeters Market would witness market growth of 7.2% CAGR during the forecast period (2022-2028).
Traditional pulse oximetry analyzes arterial hemoglobin oxygen saturation and pulse rate using two wavelengths of light (red and infrared) sent through a finger and a photodetector. Extended analysis of the photo plethysmographic waveform; use of multiple wavelengths of light to quantify methemoglobin, carboxyhemoglobin, and total hemoglobin content in blood; and use of electronic processes to improve pulse oximeter signal processing during low signal-to-noise ratio conditions are just a few of the recent advances in pulse oximetry. These advancements have given pulse oximeters new clinical uses that will have an impact on patient monitoring and treatment and will propel the smart pulse oximetry market.
Patients with chronic obstructive pulmonary disease (COPD) may experience low blood oxygen levels. Pulse oximetry is used to evaluate peripheral blood oxygen saturation (SpO2) during the day using a spot check or continuously for one or two nights to determine nocturnal desaturation. Natural changes in SpO2 may be missed if samples are taken at this frequency.
Cardiovascular diseases (CVD) remain the leading cause of death in Europe, responsible for 45 percent of all deaths. More than 4 million Europeans die each year from cardiovascular disease (CVD), the most common of which is coronary heart disease (CHD) and stroke. Many more people are admitted to hospitals, and many more develop long-term disabilities that require lifelong treatment. CVD has significant economic consequences for Europe, in addition to human suffering. CVD is expected to cost the EU economy €210 billion per year, including direct health-care costs as well as non-health costs including lost productivity and informal care for CVD patients. Central and Eastern Europe (CEE/CIS) has the highest rate of cardiovascular disease mortality in the world. This has raised the necessity of smart pulse oximeters in the region.
The Germany market dominated the Europe Smart Pulse Oximeters Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $160.1 Million by 2028. The UK market is anticipated to grow at a CAGR of 6.3% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 8% during (2022 - 2028).
Based on Type, the market is segmented into Fingertip, Hand held, Wrist worn, and Pediatric. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Home Environment. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Masimo Corporation. Koninklijke Philips N.V., Medtronic PLC, Omron Corporation, Smiths Group PLC, Contec Medical Systems Co., Ltd., Meditech Equipment Co .,Ltd (Meditech Group), Nonin Medical, Inc., Promed Technology Co., Ltd., and Tenko Medical System Corp.
Scope of the Study
Market Segments covered in the Report:
By Type
The Europe Smart Pulse Oximeters Market would witness market growth of 7.2% CAGR during the forecast period (2022-2028).
Traditional pulse oximetry analyzes arterial hemoglobin oxygen saturation and pulse rate using two wavelengths of light (red and infrared) sent through a finger and a photodetector. Extended analysis of the photo plethysmographic waveform; use of multiple wavelengths of light to quantify methemoglobin, carboxyhemoglobin, and total hemoglobin content in blood; and use of electronic processes to improve pulse oximeter signal processing during low signal-to-noise ratio conditions are just a few of the recent advances in pulse oximetry. These advancements have given pulse oximeters new clinical uses that will have an impact on patient monitoring and treatment and will propel the smart pulse oximetry market.
Patients with chronic obstructive pulmonary disease (COPD) may experience low blood oxygen levels. Pulse oximetry is used to evaluate peripheral blood oxygen saturation (SpO2) during the day using a spot check or continuously for one or two nights to determine nocturnal desaturation. Natural changes in SpO2 may be missed if samples are taken at this frequency.
Cardiovascular diseases (CVD) remain the leading cause of death in Europe, responsible for 45 percent of all deaths. More than 4 million Europeans die each year from cardiovascular disease (CVD), the most common of which is coronary heart disease (CHD) and stroke. Many more people are admitted to hospitals, and many more develop long-term disabilities that require lifelong treatment. CVD has significant economic consequences for Europe, in addition to human suffering. CVD is expected to cost the EU economy €210 billion per year, including direct health-care costs as well as non-health costs including lost productivity and informal care for CVD patients. Central and Eastern Europe (CEE/CIS) has the highest rate of cardiovascular disease mortality in the world. This has raised the necessity of smart pulse oximeters in the region.
The Germany market dominated the Europe Smart Pulse Oximeters Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $160.1 Million by 2028. The UK market is anticipated to grow at a CAGR of 6.3% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 8% during (2022 - 2028).
Based on Type, the market is segmented into Fingertip, Hand held, Wrist worn, and Pediatric. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Home Environment. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Masimo Corporation. Koninklijke Philips N.V., Medtronic PLC, Omron Corporation, Smiths Group PLC, Contec Medical Systems Co., Ltd., Meditech Equipment Co .,Ltd (Meditech Group), Nonin Medical, Inc., Promed Technology Co., Ltd., and Tenko Medical System Corp.
Scope of the Study
Market Segments covered in the Report:
By Type
- Fingertip
- Hand held
- Wrist worn
- Pediatric
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Home Environment
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Masimo Corporation
- Koninklijke Philips N.V.
- Medtronic PLC
- Omron Corporation
- Smiths Group PLC
- Contec Medical Systems Co., Ltd.
- Meditech Equipment Co .,Ltd (Meditech Group)
- Nonin Medical, Inc.
- Promed Technology Co., Ltd.
- Tenko Medical System Corp
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
69 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Smart Pulse Oximeters Market, by Type
- 1.4.2 Europe Smart Pulse Oximeters Market, by End User
- 1.4.3 Europe Smart Pulse Oximeters Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Recent Strategies Deployed in Smart Pulse Oximeters Market
- Chapter 4. Europe Smart Pulse Oximeters Market by Type
- 4.1 Europe Fingertip Market by Country
- 4.2 Europe Hand held Market by Country
- 4.3 Europe Wrist worn Market by Country
- 4.4 Europe Pediatric Market by Country
- Chapter 5. Europe Smart Pulse Oximeters Market by End User
- 5.1 Europe Hospitals & Clinics Market by Country
- 5.2 Europe Ambulatory Surgical Centers Market by Country
- 5.3 Europe Home Environment Market by Country
- Chapter 6. Europe Smart Pulse Oximeters Market by Country
- 6.1 Germany Smart Pulse Oximeters Market
- 6.1.1 Germany Smart Pulse Oximeters Market by Type
- 6.1.2 Germany Smart Pulse Oximeters Market by End User
- 6.2 UK Smart Pulse Oximeters Market
- 6.2.1 UK Smart Pulse Oximeters Market by Type
- 6.2.2 UK Smart Pulse Oximeters Market by End User
- 6.3 France Smart Pulse Oximeters Market
- 6.3.1 France Smart Pulse Oximeters Market by Type
- 6.3.2 France Smart Pulse Oximeters Market by End User
- 6.4 Russia Smart Pulse Oximeters Market
- 6.4.1 Russia Smart Pulse Oximeters Market by Type
- 6.4.2 Russia Smart Pulse Oximeters Market by End User
- 6.5 Spain Smart Pulse Oximeters Market
- 6.5.1 Spain Smart Pulse Oximeters Market by Type
- 6.5.2 Spain Smart Pulse Oximeters Market by End User
- 6.6 Italy Smart Pulse Oximeters Market
- 6.6.1 Italy Smart Pulse Oximeters Market by Type
- 6.6.2 Italy Smart Pulse Oximeters Market by End User
- 6.7 Rest of Europe Smart Pulse Oximeters Market
- 6.7.1 Rest of Europe Smart Pulse Oximeters Market by Type
- 6.7.2 Rest of Europe Smart Pulse Oximeters Market by End User
- Chapter 7. Company Profiles
- 7.1 Masimo Corporation
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expenses
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Partnerships, Collaborations, and Agreements:
- 7.1.5.2 Product Launches and Product Expansions:
- 7.2 Koninklijke Philips N.V.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.4.1 Acquisition and Mergers:
- 7.3 Medtronic PLC
- 7.3.1 Company overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expenses
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Approvals and Trials:
- 7.4 Omron Corporation
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.5 Smiths Group PLC
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expenses
- 7.6 Contec Medical Systems Co., Ltd.
- 7.6.1 Company Overview
- 7.7 Meditech Equipment Co .,Ltd (Meditech Group)
- 7.7.1 Company Overview
- 7.8 Nonin Medical, Inc.
- 7.8.1 Company Overview
- 7.8.2 Recent strategies and developments:
- 7.8.2.1 Product Launches and Product Expansions:
- 7.8.2.2 Approvals and Trials:
- 7.9 Promed Technology Co., Ltd.
- 7.9.1 Company Overview
- 7.10. Tenko Medical System Corp
- 7.10.1 Company Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
